SOX15 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of SOX15, a protein encoded by the SOX15 gene. SOX15, or SRY-box transcription factor 15, is a member of the SOX (SRY-related HMG-box) family of transcription factors, which play crucial roles in regulating gene expression during development and differentiation. SOX15 is involved in various developmental processes, including muscle development and differentiation, where it acts by binding to specific DNA sequences and regulating the transcription of target genes. This regulation is vital for the proper formation and function of tissues during embryogenesis and in maintaining the homeostasis of adult tissues.
Structurally, SOX15 inhibitors can vary widely, encompassing small molecules, peptides, or larger biomolecules that are engineered to interact specifically with the DNA-binding domain or other critical regions of the SOX15 protein. These inhibitors typically function by preventing SOX15 from binding to its target DNA sequences, thereby blocking its ability to regulate gene transcription. By inhibiting SOX15, these compounds can disrupt the transcriptional networks controlled by this factor, leading to changes in the expression of genes involved in cellular differentiation and development. The study of SOX15 inhibitors is crucial for understanding the regulatory mechanisms underlying SOX15's role in gene expression and its impact on developmental processes. Research into these inhibitors provides valuable insights into the broader implications of transcription factor regulation in cellular biology, highlighting the importance of precise control of gene expression in maintaining cellular identity and function. By exploring the effects of SOX15 inhibition, scientists can gain a deeper understanding of the intricate networks of gene regulation and the role of transcription factors in orchestrating the complex processes of development and differentiation.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
Bloque l'activation de l'Akt, qui régule ensuite à la baisse l'expression de SOX (facteur de transcription à boîte SRY) via la voie PI3K/Akt. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibe le récepteur de type I du TGF-&bêta, empêchant l'augmentation de l'expression de SOX (facteur de transcription à boîte SRY) induite par le TGF-&bêta dans les cellules de la crête neurale. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibe la protéine kinase associée à Rho (ROCK), ce qui a un impact sur la migration des cellules de la crête neurale et probablement sur les processus liés à SOX (facteur de transcription à boîte SRY). | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $97.00 $212.00 $500.00 | 11 | |
Régule à la baisse l'expression de SOX (facteur de transcription à boîte SRY) en modulant les voies de signalisation MAPK, qui jouent un rôle dans le développement des cellules de la crête neurale. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $150.00 $455.00 | 20 | |
Inhibe l'adénosine kinase, entraînant une augmentation des niveaux d'adénosine qui peut moduler les voies de signalisation liées à SOX (facteur de transcription à boîte SRY). | ||||||